AI Verdict
HOMB has stronger fundamentals based on our AI analysis.
HOOK vs HOMB Fundamental Comparison
| Metric | HOOK | HOMB |
|---|---|---|
| Revenue | $2.0M | $1.3B |
| Net Income | $-15.4M | $475.4M |
| Net Margin | -769.8% | 37.2% |
| ROE | -45.3% | 11.1% |
| ROA | -25.2% | 2.1% |
| Current Ratio | 3.61x | N/A |
| Debt/Equity | 0.03x | 0.30x |
| EPS | $-1.23 | $2.41 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HOOK vs HOMB: Frequently Asked Questions
Is HOOK or HOMB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HOMB has stronger fundamentals. HOOK is rated SELL (45% confidence) while HOMB is rated BUY (72% confidence). This is not investment advice.
How does HOOK compare to HOMB fundamentally?
HOOKIPA Pharma Inc. has ROE of -45.3% vs HOME BANCSHARES INC's 11.1%. Net margins are -769.8% vs 37.2% respectively.
Which stock pays higher dividends, HOOK or HOMB?
HOOK has a dividend yield of N/A or no dividend while HOMB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HOOK or HOMB for long term?
For long-term investing, consider that HOOK has SELL rating with 45% confidence, while HOMB has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HOOK vs HOMB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HOOK vs HOMB, the AI consensus favors HOMB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.